LUMASIRAN for Primary hyperoxaluria: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 176 adverse event reports in the FDA FAERS database where LUMASIRAN was used for Primary hyperoxaluria.
Most Reported Side Effects for LUMASIRAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Renal transplant | 38 | 13.6% | 1 | 8 |
| Nephrolithiasis | 22 | 7.9% | 0 | 4 |
| Drug ineffective | 15 | 5.4% | 0 | 1 |
| Hospitalisation | 15 | 5.4% | 0 | 15 |
| Urine oxalate increased | 14 | 5.0% | 0 | 2 |
| Acute kidney injury | 11 | 3.9% | 0 | 3 |
| Liver transplant | 11 | 3.9% | 1 | 2 |
| Laboratory test abnormal | 9 | 3.2% | 0 | 2 |
| Product dose omission issue | 9 | 3.2% | 0 | 3 |
| Death | 8 | 2.9% | 8 | 0 |
| Dialysis | 8 | 2.9% | 0 | 0 |
| Hyperoxalaemia | 8 | 2.9% | 0 | 0 |
| Intentional dose omission | 8 | 2.9% | 0 | 6 |
| Diarrhoea | 7 | 2.5% | 1 | 1 |
| End stage renal disease | 7 | 2.5% | 0 | 0 |